Live Breaking News & Updates on Maintenance Pemetrexed

Stay updated with breaking news from Maintenance pemetrexed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Phase 3 Trial of Pembrolizumab with Olaparib Did Not Meet Endpoints Among Individuals with NSCLC

Pembrolizumab in combination with chemotherapy followed by maintenance olaparib did not meet its pre-specified statistical criteria of overall survival or progression free survival. ....

Gregory Lubiniecki , Merck Sharp Dohme , Merck Research Laboratories , Pembrolizumab With Maintenance Olaparib , Maintenance Pemetrexed , Metastatic Nonsquamous Non Small Cell Lung Cancer , Merck Sharp , Provides Update , Plus Maintenance Lynparza ,